肾移植后红细胞增多症的临床流行病学研究

An epidemiological study of post transplant erythrocytosis

对肾移植后红细胞增多症（ＰＴＥ）的临床流行病学进行研究。在本中心完成的９０１例同种异体尸肾移植病人中，共发生肾移植后ＰＴＥ８４例，发病率为９．３％，发生于移植后１６．８±１１．３个月。就其性别组成、移植前Ｈｂ、移植前后高血压发病情况、利尿剂应用、免疫抑制药、自体肾是否切除、移植后发病前ＳＣｒ／ＢＵＮ（血肌酐／尿素氮）及移植前淋巴毒试验结果等，与非ＰＴＥ组对照，发现ＰＴＥ好发于移植前Ｈｂ相对较高、移植前后血压较高、不服用Ａｚａ而肾功能良好的男性肾移植病人。

post transplant erythrocytosis (PTE) was found in 901 renal transplant recipients in our transplantation center (9.3%), occuring most commonly 1～2 years after the kidney transplantation. The sex proportion, pretransplant Hb, pre and post transplant BP, immunosuppressives and diuretics instituted, pretransplant lymphocytotoxicity and pre PTE Scr/BUN were reviewed and analysed. PTE has been found to be more prevalent in non Aza treated male patients with good renal function, in patients with relative higher pretransplant Hb and in patients with high pre and post transplant blood pressure.